NCT07576127 Effects of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in Patients With Adhesive Capsulitis
| NCT ID | NCT07576127 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Adhesive Capsulitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2025-09-01 with a primary completion date of 2026-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The randomized controlled trail aims is to evaluate the outcome of Gongs mobilization and PNF in patients with adhesive capsulitis. The significance of this study is to compare Gong's mobilization technique with proprioceptive neuromuscular facilitation (PNF) compare their effects on pain, range of motion, and functional disability. The sample size was calculated with G-power. This study would include total 44 female participants aged 40-60 years will be recruited and randomly assigned to two groups. Group A(Gongs mobilization+ conventional therapy)and Group B(PNF+ Conventional therapy). Intervention will be provided for 4 weeks 3 session per week. Primary outcome measures are pain, ROM and functional disability via NPRS, Goniometer and U-SPADI. Outcomes will be reassessed at baseline, after 2nd week, and after 4th week.
Eligibility Criteria
Inclusion Criteria: * Females in the age group between 40-60 years. * Diagnosed with Unilateral frozen shoulder. * Patients in frozen stage (progressive loss of ROM, marked stiffness with gradual pain reduction). * More than 25% painful limitation of GH ROM in two planes, more than 50% in external rotation(arm at 0 degree of abduction). Exclusion Criteria: * History of surgery on the affected shoulder. * Patients having any cervical or thoracic problem. * Painful, stiff shoulder after severe trauma, inflammatory diseases such as rheumatoid arthritis and malignancies. * Recent fractures in and around the shoulder. * Rotator cuff disorder.
Contact & Investigator
Fatima Miraj, DPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576127 clinical trial?
This trial is open to female participants only, aged 40 Years or older, up to 60 Years, studying Adhesive Capsulitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576127 currently recruiting?
Yes, NCT07576127 is actively recruiting participants. Contact the research team at fatimamiraj921@gmail.com for enrollment information.
Where is the NCT07576127 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT07576127 clinical trial?
NCT07576127 is sponsored by Riphah International University. The principal investigator is Fatima Miraj, DPT at Riphah International University. The trial plans to enroll 44 participants.